Register
Question 1
A psychiatric nurse explains that therapeutic effects may not occur for several weeks with an antidepressant. The nurse understands this is likely due to what?
Correct Answer:
Changes in the brain as a result of prolonged drug exposure
Explanation:
Therapeutic effects from antidepressants take weeks because the brain must undergo adaptive changes after the drug is started. While the medication quickly increases monoamine levels in the synapse, the mood improvements come from slower downstream processes—altered receptor sensitivity, changes in gene expression, and increased neurotrophic signaling like brain-derived neurotrophic factor that promote neuroplasticity and hippocampal neurogenesis. These neuroadaptive changes unfold over time, explaining the delay before clinical benefit appears. The other ideas don’t fit this pattern: the blood-brain barrier doesn’t account for a delayed response, tolerance would more likely reduce effect rather than delay it, and rapid onset of adverse effects doesn’t explain a gradual improvement in mood.
Question 2
A patient with peptic ulcer disease does not smoke and drinks wine infrequently with meals. Which regimen is appropriate?
Correct Answer:
Amoxicillin, clarithromycin, and omeprazole
Explanation:
Treating H. pylori–associated peptic ulcer disease with a proton pump inhibitor–based triple therapy is the standard approach. The PPI creates a less acidic environment that helps antibiotics work better and promotes ulcer healing. Amoxicillin and clarithromycin attack the bacteria in complementary ways—amoxicillin disrupts cell wall synthesis, while clarithromycin inhibits protein synthesis—leading to effective eradication when clarithromycin resistance is not high in the area. This regimen—amoxicillin, clarithromycin, and a PPI (such as omeprazole)—is preferred because it combines a strong acid-suppressing agent with two antibiotics that have good activity against H. pylori, yielding high eradication rates in appropriate settings. Regimens that swap in an H2 blocker instead of a PPI are less ideal due to weaker acid suppression and lower eradication effectiveness. regimens that omit one of the key antibiotics or rely on agents like sucralfate, which can interfere with antibiotic absorption, are also not first-line choices. Additionally, metronidazole-containing options raise concerns with alcohol use due to potential disulfiram-like reactions, which is another reason this particular combination is preferred for a patient who drinks wine infrequently.
Question 3
An adult patient has two office visits with blood pressures of 150/95 mmHg and 148/90 mmHg, and ambulatory reading of 145/92 mmHg. All diagnostic tests are normal. Which treatment is most appropriate to initiate?
Correct Answer:
A thiazide diuretic
Explanation:
When managing uncomplicated essential hypertension, a thiazide diuretic is the most appropriate first-line starting therapy. These agents have robust evidence showing they reduce major cardiovascular events and are cost-effective, well tolerated in many patients, and reliably lower blood pressure with once-daily dosing. In a patient with persistently elevated blood pressure across multiple visits and a normal workup, there are no compelling indications for a beta-blocker, loop diuretic, or calcium channel blocker that would trump starting a thiazide. Beta-blockers are generally reserved for compelling indications such as coronary artery disease, arrhythmias, or heart failure, and they’re not the preferred initial choice for uncomplicated hypertension. Loop diuretics are powerful diuretics that are excellent for edema or volume overload (and certain kidney diseases) but they don’t offer the same long-term cardiovascular risk reduction seen with thiazides in primary hypertension. Calcium channel blockers are effective and can be used as first-line in some patients, but thiazides have the broadest support for initial management of uncomplicated HTN due to strong outcome data and cost considerations. Starting a thiazide now, with plans to monitor blood pressure and electrolytes, aligns with best practice for initial therapy in this scenario.
Question 4
Which prognosis best describes Stage D heart failure?
Correct Answer:
Poor prognosis with limited response to conventional therapies
Explanation:
Stage D describes advanced heart failure with persistent symptoms despite optimized medical therapy. In this stage the disease has progressed to a point where conventional treatments provide limited benefit, and mortality and morbidity remain high. Diuretics help relieve congestion but don’t improve long-term survival, so an excellent prognosis with diuretics isn’t accurate. Device therapies can help some patients by reducing arrhythmias or improving heart function, but they do not reverse the overall trajectory for most with Stage D, so saying there’s no impact from device therapy isn’t correct. Reversibility with medication alone is not typical at this stage, as the heart failure tends to be progressive and often requires consideration of advanced therapies or palliative approaches. All of this makes the description of a poor prognosis with limited response to conventional therapies the best fit for Stage D.
Question 5
A patient with stable COPD receives prescriptions for an inhaled glucocorticoid and an inhaled beta2-adrenergic agonist. Which statement indicates understanding of this medication regimen?
Correct Answer:
The glucocorticoid is used as prophylaxis to prevent exacerbations.
Explanation:
Inhaled corticosteroids in COPD are used to reduce airway inflammation and lower the risk of exacerbations over time. They are a maintenance, preventive therapy rather than a rescue treatment for an acute flare. That’s why saying the glucocorticoid is used prophylactically to prevent exacerbations best reflects its role in a stable COPD regimen. The inhaled beta2-adrenergic agonist provides bronchodilation. If it’s the long-acting type, it’s taken daily to prevent symptoms as part of maintenance therapy; if it’s the short-acting type, it’s used as needed for quick relief. The key point is that the anti-inflammatory agent is aimed at preventing exacerbations, while the bronchodilator’s role is to keep airways open, with the maintenance vs rescue distinction depending on which beta2-agonist is prescribed. The other statements don’t fit typical COPD management: inhaled corticosteroids aren’t used PRN for acute attacks, and daily maintenance use of a beta2-agonist is common when a long-acting agent is involved, rather than using it only as needed.
Question 1
Exam overview

About this Exam

Welcome to your comprehensive study guide for the WGU NURS6800 D116 Advanced Pharmacology for the Advanced Practice Nurse Practice Exam. This is a crucial milestone on your journey toward becoming an advanced practice nurse (APN), such as a Nurse Practitioner. The course and its final objective assessment are designed to equip you with the deep, evidence-based knowledge required for safe and effective prescriptive authority.

This practice exam is a vital tool, simulating the rigor and content of the official WGU assessment. It is tailored for graduate nursing students who need to master intricate pharmacological principles, from molecular mechanisms to clinical decision-making across the lifespan. By engaging with this resource, you will build the confidence and competence needed to pass the final exam and, more importantly, to provide exceptional care to your future patients.

More details

Additional Information

What the Course Entails and Exam Details

The WGU NURS6800 D116 course is a comprehensive exploration of advanced pharmacology, going far beyond foundational knowledge. It focuses on the application of principles to solve complex clinical scenarios.

Key topics covered in the course and evaluated in the exam include:

  • Pharmacokinetics and Pharmacodynamics: Understanding drug absorption, distribution, metabolism, excretion (ADME), and the biochemical and physiological effects of drugs.

  • Mechanisms of Action: Master the precise ways that major drug classes interact with body systems at the cellular and molecular levels.

  • Drug Classifications: In-depth knowledge of agents for all major body systems, including: Neuropharmacology and Psychotropic Agents, Cardiovascular and Renal Pharmacology, Respiratory and Endocrine Pharmacology, and Gastrointestinal and Antimicrobial Agents.

  • Therapeutic Applications and Clinical Decision-Making: Learning to select the most appropriate drug therapy based on patient-specific factors, including genetics, comorbidities, and special populations (pediatrics, geriatrics, pregnancy).

  • Adverse Effects, Interactions, and Safety: Recognizing, managing, and preventing adverse drug reactions and drug-drug, drug-food, and drug-disease interactions.

  • Evidence-Based Prescribing: Applying current guidelines and research to develop safe, effective, and ethical therapeutic regimens.


What to Expect in the Final Exam

The final assessment for D116 is an Objective Assessment (OA), which means it is a proctored, multiple-choice exam. The questions are often scenario-based, requiring you to apply your knowledge to make clinical decisions rather than just recalling facts.

Here are the key exam details you need to know:

  • Format: Multiple-choice questions.

  • Time Limit: You will typically have a set amount of time, often around 2 to 3 hours, to complete the exam. It is essential to manage your time wisely.

  • Passing Score: WGU uses a competency-based model. The cut score, or passing requirement, is set to ensure you have met all course competencies. While the exact percentage can vary slightly, you should aim for mastery of all content areas.

  • Proctoring: The OA is taken via an online proctoring service. You will need a reliable internet connection, an external webcam, and a private space free of distractions. Specific WGU proctoring guidelines must be followed.

  • Calculators: Depending on the current policy, an on-screen calculator may be provided for any necessary dosage or pharmacokinetic calculations.


How to Study and Exam Centers

Effective preparation for the D116 OA requires a systematic and active study approach. Because the course is competency-based, your focus must be on understanding, not just memorization.

Actionable Study Strategies:

  1. Utilize WGU Resources: Thoroughly complete all course modules, read the assigned text, and engage with learning activities. Pay close attention to the course competencies; they are the blueprint for the exam.

  2. Take the Pre-Assessment (PA): The WGU D116 Pre-Assessment is your best diagnostic tool. Take it early to identify your areas of weakness. Your personalized coaching report will guide your studies.

  3. Active Learning: Create your own study aids. Develop flashcards for drug classes, mechanisms, and major adverse effects. Write summary notes for each body system.

  4. Case Study Practice: Practice applying your knowledge to clinical scenarios. Use case studies to walk through the complete process of assessment, drug selection, monitoring, and patient education.

  5. Study Groups: Collaborate with peers. Discussing complex topics can reinforce your understanding and expose you to new perspectives.

  6. Practice Questions: Seek out practice questions, like those in this WGU NURS6800 D116 Advanced Pharmacology Practice Exam resource. Analyze rationales for both correct and incorrect answers.

Exam Center and Taking the Test:

The final Objective Assessment is taken through WGU's online proctoring portal, meaning you can take it from the comfort of your home or any private, suitable location. You do not need to visit a physical Pearson VUE center. WGU ensures the integrity of the exam through strict online proctoring protocols.


Job Opportunities from the Course

Successful completion of this course and the broader graduate nursing program unlocks a variety of impactful and rewarding career paths in advanced practice. Mastering advanced pharmacology is a cornerstone skill for these roles.

This course unlocks career paths including:

  • Nurse Practitioner (NP)

  • Certified Nurse-Midwife (CNM)

  • Certified Registered Nurse Anesthetist (CRNA)

  • Clinical Nurse Specialist (CNS)

  • Nurse Educator

  • Nursing Leadership and Management

  • Clinical Research Nurse

We wish you the very best in your studies for the WGU NURS6800 D116 Advanced Pharmacology exam! Stay focused, use your resources, and believe in your ability to succeed.


Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions

307 Advanced Damage Control Practice Exam

0 min

3CX Academy Advanced Certification Practice Exam

0 min

Archer Pharmacology & Dosage Calc Practice Exam

0 min

Arizona State University (ASU) BIO201 Human Anatomy and Physiology I Exam 3 Practice Study Guide

0 min

Certified Transport Registered Nurse Certification Practice Exam

0 min

Arizona State University (ASU) BIO345 Evolution Exam 1 Practice

0 min